Peters, Edgar

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,662

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,229

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science

Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research

Cited by 408

Prehospital antibiotics in the ambulance for sepsis: A multicentre, open label, randomised trial.

Alam, N., Oskam, E., Stassen, P. M., Exter, P. V., van de Ven, P. M., Haak, H. R., Holleman, F., Zanten, A. V., Leeuwen-Nguyen, H. V., Bon, V., et al. (2018) · The Lancet Respiratory Medicine

Sepsis Diagnosis and TreatmentTrauma and Emergency Care Studies

Cited by 290

Hyperbaric oxygen therapy in the treatment of ischemic lower- extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial.

Santema, K. T. B., Stoekenbroek, R. M., Koelemay, M. J. W., Reekers, J. A., van Dortmont, L. M. C., Oomen, A., Smeets, L., Wever, J. J., Legemate, D. A., Ubbink, D. T., et al. (2018) · Diabetes Care

Diabetic Foot Ulcer Assessment and ManagementPeripheral Artery Disease Management

Cited by 170